OIA
MAIA icon

Optimum Investment Advisors’s MAIA Biotechnology MAIA Stock Holding History

Optimum Investment Advisors’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000
Closed -$3K – 803
2022
Q3 		$3K Buy
+1,000
New +$4.23K ﹤0.01% 696

Other funds holding MAIA

LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Optimum Investment Advisors's MAIA Position: Q4 2022 in Review

Optimum Investment Advisors sold out of MAIA Biotechnology (MAIA) in Q4 2022, closing a stake of 1,000 shares — an estimated $3K sold.

Optimum Investment Advisors first reported a position in MAIA in Q3 2022 and held it in 1 quarter. The position peaked at $3K in Q3 2022. 6 funds tracked by Wall St. Rank hold MAIA as of Q4 2022.

  • Optimum Investment Advisors reported no remaining MAIA Biotechnology position as of Q4 2022 after selling out during the quarter.
  • Optimum Investment Advisors sold 1,000 MAIA Biotechnology shares in Q4 2022, an estimated $3K.
  • Optimum Investment Advisors first reported a position in MAIA Biotechnology in Q3 2022 and held it in 1 quarter.
  • Optimum Investment Advisors's MAIA Biotechnology position peaked at $3K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q4 2022.

Based on Optimum Investment Advisors's 13F filing for Q4 2022, filed 5 Jan 2023.